Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-29

Clinical Trial Update: Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update for a fixed-dose inhaled combination of beclometasone, formoterol, and glycopyrrolate in chronic obstructive pulmonary disease has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beclometasone + Formoterol + Glycopyrrolate fixed combination

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED